SLC5A2 and keratitis: Besides, there were 166 and 251 infectious keratitis events in the SGLT2 inhibitors and control groups, and the patients in SGLT2 inhibitors group also revealed a significantly lower infectious keratitis incidence than the control group according to the Cox proportional hazard regression (aHR: 0.654, 95% CI: 0.537-0.796, P < 0.0001) (Table 2 and 3).